Melanoma incidence mortality rates and clinico-pathological types in the Siberian area of the Russian federation

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 5, 2014, Pages 2201-2204

  Gyrylova, Svetlana Nikolaevna ^a   Aksenenko, Mariya Borisovna ^a   Gavrilyuk, Dmitriy Vladimirovich ^a   Palkina, Nadezda Vladimirovna ^a   Dyhno, Yuriy Alexandrovich ^a   Ruksha, Tatiana Gennadievna ^a   Artyukhov, Ivan Pavlovich ^a  

^a KRASNOYARSK STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Incidence; Melanoma; Mortality; Russian federation; Siberia

Indexed keywords

AGED; EPIDEMIOLOGY; FEMALE; HUMAN; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; RUSSIAN FEDERATION;

AGED; FEMALE; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; RETROSPECTIVE STUDIES; RUSSIA;

EID: 84899085980     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.5.2201     Document Type: Article

References (27)

1. Azarjana K, Ozola A, Ruklisa D, et al (2012). Melanoma epidemiology, prognosis and trends in Latvia. J Eur Acad Dermatol Venereol, 27, 1352-9.
2. Balch CM, Gershenwald JE, Soong SJ, et al (2011). Update on the melanoma staging system: the importance of sentinel node staging and primary tumor mitotic rate. J Surg Oncol, 104, 379-5.
3. Bradford PT, Anderson WF, Purdue Mp, et al (2010). Rising melanoma incidence rates of the trunk among young women in the United States. Cancer Epidemiol Biomarkers Prev, 19, 2401-6.
4. Busam KJ, Antonescu CR, Marghoob AA, et al (2001). Histologic classification of tumor-infiltrating lymphocytes in primary cutaneous malignant melanoma: a study of interobserver agreement. Am J Clin Pathol, 115, 856-60.
5. Chissov VI, Starinsky VV, Petrova GV (2011). Cancer in Russia in 2010 (incidence and mortality). Moscow: Herzen Moscow Research Oncology Institute, pp 15-7.
6. Clark WH, Elder DE, Guerry D, et al (1981). A model for predicting survival in stage 1 melanoma based upon tumor progression. J Natl Cancer Inst, 81, 1893-4.
7. Curado MP, Edwards B, Shin HR, et al (2007). Cancer incidence in five continents (Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, eds), Lyon: IARC scientific publications, pp 280-8.
8. Deichmann M, Krahl D, Thome M, et al (2006). The oncogenic B-raf V599E mutation occurs more frequently in melanomas at sun-protected body sites. Int J Oncol, 29, 139-5.
9. Elwood JM, Gallagher RP (1998) Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure. Int J Cancer, 78, 276-80.
10. Erdman F, Lortet-Tieulent J, Schuz J, et al (2013). International trends in the incidence of malignant melanoma 1953-2008-are recent generations at higher or lower risk? Int J Cancer, 132, 385-90.
11. Forsea AM, Marmol Del V, Vries de E, et al (2012). Melanoma incidence and mortality in Europe: new estimates, persistent disparities. Br J Dermatol, 167, 1124-30.
12. Fuglede NB, Brinck-Claussen UO, Deltour I, et al (2011). Incidence of cutaneous malignant melanoma in Denmark, 1978-2007. Br J Dermatol, 165, 349-53.
13. Jemal A, Saraiya M, Patel P, et al (2011). Recent trends in cutaneous melanoma incidence and death rates in the United States. J Am Acad Dermatol, 65, 17-5.
14. Joosse A, Vries de E, Eckel R, et al (2011). Gender differences in melanoma survival: female patients have a decreased risk of metastasis. J Invest Dermatol, 131, 719-26.
15. MacKie RM, Bray C, Vestey J (2003) Melanoma incidence and mortality in Scotland 1979-2003. Br J Cancer, 96, 1772-7.
16. Micu E, Baturaite Z, Juzeniene A, et al (2012). Superficialspreading and nodular melanomas in Norway: a comparison by body site distribution and latitude gradients. Melanoma Res, 22, 460-5.
17. Mocellin S, Nitti D (2001). Cutaneous melanoma in situ: translation evidence from a large population-based study. Oncologist, 16, 896-3.
18. Pleasance ED, Cheetham RK, Stephens PJ (2010) A comprehensive catalogue of somatic mutations from a human cancer genome. Nature, 463, 191-6.
19. Pruthi DK, Guilfoyle R, Nugent Z, et al (2009). Incidence and anatomic presentation of cutaneous malignant melanoma in central Canada during a 50-year period: 1956 to 2005. J Am Acad Dermatol, 61, 44-0.
20. Rao UNM, Lee SJ, Luo W, et al (2010). Presence of tumorinfiltrating lymphocytes and a dominant nodule within primary melanoma are prognostic factors for relapse-free survival of patients with thick (T4) primary melanoma: pathologic analysis of the E1690 and E1694 intergroup trials. Am J Clin Pathol, 133, 646-53.
21. Richards TB, Johnson CJ, Tatalovich Z, et al (2011). Association between cutaneous melanoma incidence rates among white US residents and country-level estimates of solar ultraviolet exposure. J Am Acad Dermatol, 2011, 50-7.
22. Schubert A (2012) Malignant melanoma of the skin: does screening for cancer influence the incidence and mortality? Gesundheitswesen, 74, 154-9.
23. Singh SD, Ajani UA, Johnson CJ, et al (2011). Association of cutaneous melanoma incidence with area-based socioeconomic indicators-United States, 2004-2006. J Am Acad Dermatol, 65, 58-8.
24. Tsai T, Vu C, Henson DE (2005) Cutaneous, ocular and visceral melanoma in African Americans and Caucasians. Melanoma Res, 15, 213-7.
25. Van der Aa MA, de Vries E, Hoekstra HJ, et al (2011). Sociodemographic factors and incidence of melanoma in the Netherlands. Eur J Cancer, 47, 1056-0.
26. Weir HK, Marrett LD, Cokkinides V, et al (2011). Melanoma in adolescents and young adults (ages 15-39 years): United States, 1999-2006. J Am Acad Dermatol, 65, 38-9.
27. Youl PH, Youlden DR, Baade PD (2012). Changes in the site distribution of common melanoma syb-types in Queensland, Australia over time: implications for public health campaigns. Br J Dermatol, 168, 136-4.